why choose us

300×250 Ad Slot

Research Article: Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions

Date Published: 2023-12-02

Abstract:
The prevalence of neurological disorders is high among the Mexican population. Clonazepam is primarily indicated to treat panic disorders, certain kinds of epilepsy such as status epilepticus, childhood motor seizures (petit mal absence, Lennox–Gastaut syndrome, and infantile spasms), anxiety, and muscle spasm. This study was performed to compare bioequivalence between two oral tablet formulations of clonazepam 2 mg in healthy Mexican volunteers under fasting conditions.

Introduction:
Epilepsy is a neurological disorder affecting 50 million people worldwide [1]. In Mexico, the prevalence of epilepsy is estimated between 1 and 2 million people [2]. The Mexican National Comorbidity Survey reported a high lifetime prevalence of psychiatric disorders in the Mexican population, the most common being anxiety (14.3%) and mood disorders (9.2%) [3]. About 35.8% of Mexican adolescents suffered from depression or generalized anxiety disorder [4]. Clonazepam is a high-potency and long-acting…

Read more

300×250 Ad Slot